We then treated primary HSCs with one of the hydrophobic bile acids, taurolithocholic acid (TLCA; Sigma), to explore whether miR-29a affects HDAC4 expression and nuclear translocation in response to cholestasis. The gene discussed is HDAC4; the disease is cholestasis.